Oxazole compound and pharmaceutical composition

Details for Australian Patent Application No. 2006316079 (hide)

Owner Otsuka Pharmaceutical Co., Ltd.

Inventors Shibata, Tomonori; Sato, Norifumi; Hiyama, Hidetaka; Kitagaki, Hideki; Uno, Tetsuyuki; Haruta, Junpei; Kato, Masaya; Okada, Minoru

Agent Freehills

Pub. Number AU-B-2006316079

PCT Pub. Number WO2007/058338

Priority 2005-330590 15.11.05 JP

Filing date 14 November 2006

Wipo publication date 24 May 2007

Acceptance publication date 29 March 2012

International Classifications

C07D 263/34 (2006.01) Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

A61K 31/422 (2006.01) - not condensed and containing further heterocyclic rings

A61P 17/00 (2006.01) Drugs for dermatological disorders

C07D 263/32 (2006.01) Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

8 May 2008 PCT application entered the National Phase

  PCT publication WO2007/058338 Priority application(s): WO2007/058338

29 March 2012 Application Accepted

  Published as AU-B-2006316079

26 July 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006316087-Heterocyclic compound having inhibitory activity on 11-beta-hydroxysteroid dehydrogenase type I

2006316072-Heteroalkyl linked pyrimidine derivatives